ENDOMETRIAL CANCERS

Clinical trials for ENDOMETRIAL CANCERS explained in plain language.

Never miss a new study

Get alerted when new ENDOMETRIAL CANCERS trials appear

Sign up with your email to follow new studies for ENDOMETRIAL CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Engineered immune cells take on Hard-to-Treat ovarian and endometrial cancers

Disease control Not yet recruiting

This early-phase trial tests a one-time treatment called OPB-201, where a patient's own immune cells are modified in a lab to better recognize and attack cancer cells that carry a protein called PRAME. The study will enroll 30 adults with recurrent endometrial cancer or platinum-…

Matched conditions: ENDOMETRIAL CANCERS

Phase: PHASE1 • Sponsor: Outpace Bio, Inc. • Aim: Disease control

Last updated Jun 27, 2026 14:02 UTC

ENDOMETRIAL CANCERS

Get alerted when new ENDOMETRIAL CANCERS trials appear

Engineered immune cells take on Hard-to-Treat ovarian and endometrial cancers